Treace Medical Concepts (TMCI) Competitors $6.17 0.00 (0.00%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$6.17 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMCI vs. TNDM, CDRE, LQDA, AORT, SSII, PLSE, FNA, KMTS, BLFS, and ESTAShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Tandem Diabetes Care (TNDM), Cadre (CDRE), Liquidia (LQDA), Artivion (AORT), SS Innovations International (SSII), Pulse Biosciences (PLSE), Paragon 28 (FNA), Kestra Medical Technologies (KMTS), BioLife Solutions (BLFS), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. Treace Medical Concepts vs. Its Competitors Tandem Diabetes Care Cadre Liquidia Artivion SS Innovations International Pulse Biosciences Paragon 28 Kestra Medical Technologies BioLife Solutions Establishment Labs Treace Medical Concepts (NASDAQ:TMCI) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, community ranking, earnings, dividends, media sentiment, risk and analyst recommendations. Do analysts rate TMCI or TNDM? Treace Medical Concepts presently has a consensus price target of $10.16, suggesting a potential upside of 64.62%. Tandem Diabetes Care has a consensus price target of $34.15, suggesting a potential upside of 58.49%. Given Treace Medical Concepts' higher possible upside, equities research analysts clearly believe Treace Medical Concepts is more favorable than Tandem Diabetes Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Tandem Diabetes Care 0 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.43 Does the media prefer TMCI or TNDM? In the previous week, Treace Medical Concepts had 26 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 32 mentions for Treace Medical Concepts and 6 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.05 beat Treace Medical Concepts' score of 0.12 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 4 Very Positive mention(s) 3 Positive mention(s) 22 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Tandem Diabetes Care 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is TMCI or TNDM more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to Treace Medical Concepts' net margin of -30.33%. Tandem Diabetes Care's return on equity of -44.19% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-30.33% -51.12% -26.36% Tandem Diabetes Care -14.84%-44.19%-11.99% Which has more volatility and risk, TMCI or TNDM? Treace Medical Concepts has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Does the MarketBeat Community prefer TMCI or TNDM? Tandem Diabetes Care received 564 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 60.76% of users gave Tandem Diabetes Care an outperform vote while only 44.07% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTreace Medical ConceptsOutperform Votes2644.07% Underperform Votes3355.93% Tandem Diabetes CareOutperform Votes59060.76% Underperform Votes38139.24% Which has stronger earnings & valuation, TMCI or TNDM? Treace Medical Concepts has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$210.82M1.84-$49.53M-$0.85-7.26Tandem Diabetes Care$982.95M1.46-$222.61M-$2.78-7.75 Do insiders & institutionals have more ownership in TMCI or TNDM? 84.1% of Treace Medical Concepts shares are owned by institutional investors. 27.7% of Treace Medical Concepts shares are owned by insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryTandem Diabetes Care beats Treace Medical Concepts on 10 of the 18 factors compared between the two stocks. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$388.03M$4.41B$5.57B$8.62BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-6.2328.4427.1120.06Price / Sales1.8471.85409.88157.10Price / CashN/A51.0838.2534.64Price / Book2.755.917.064.70Net Income-$49.53M$67.63M$3.23B$247.88M7 Day Performance6.93%2.35%2.88%2.66%1 Month Performance-14.31%17.24%9.04%6.40%1 Year Performance1.65%19.59%31.40%14.07% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts2.2893 of 5 stars$6.17flat$10.16+64.6%+5.5%$388.03M$210.82M-6.23250Trending NewsTNDMTandem Diabetes Care4.1392 of 5 stars$20.22+2.0%$35.86+77.3%-55.5%$1.35B$982.95M-10.482,600Positive NewsCDRECadre2.9938 of 5 stars$32.97+0.6%$37.00+12.2%+7.1%$1.34B$559.81M39.722,240LQDALiquidia3.7317 of 5 stars$16.87+13.1%$26.67+58.1%+2.3%$1.28B$14.14M-10.3550Trending NewsAnalyst ForecastOptions VolumeHigh Trading VolumeAORTArtivion2.5629 of 5 stars$28.74-2.8%$31.40+9.3%+23.6%$1.23B$390.08M-1,437.001,300Short Interest ↓SSIISS Innovations InternationalN/A$5.99-5.4%N/AN/A$1.16B$22.13M0.004Positive NewsGap UpHigh Trading VolumePLSEPulse Biosciences1.315 of 5 stars$16.88-2.5%N/A+19.2%$1.14B$700K0.00140FNAParagon 28N/A$13.11+0.1%$12.75-2.7%+98.0%$1.10B$256.18M-17.71343,000High Trading VolumeKMTSKestra Medical TechnologiesN/A$20.68-8.2%$27.50+33.0%N/A$1.06B$52.64M0.00300BLFSBioLife Solutions2.2902 of 5 stars$20.69-5.4%$31.17+50.6%+10.9%$982.78M$87.76M-19.52440Positive NewsHigh Trading VolumeESTAEstablishment Labs2.7553 of 5 stars$33.97-1.3%$55.33+62.9%-17.3%$982.31M$170.24M-13.17960Positive News Related Companies and Tools Related Companies Tandem Diabetes Care Alternatives Cadre Alternatives Liquidia Alternatives Artivion Alternatives SS Innovations International Alternatives Pulse Biosciences Alternatives Paragon 28 Alternatives Kestra Medical Technologies Alternatives BioLife Solutions Alternatives Establishment Labs Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMCI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.